Beta-blockers in atrial fibrillation—trying to make sense of unsettling results
Author:
Affiliation:
1. Department of Medicine, Lillehei Heart Institute, University of Minnesota , 2231 6th Street SE, Minneapolis, MN 55455 , USA
2. Department of Medicine, Cardiovascular Research Institute of Vermont, University of Vermont , Burlington, VT , USA
Abstract
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://academic.oup.com/europace/article-pdf/25/2/260/49724535/euad010.pdf
Reference15 articles.
1. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC;Hindricks;Eur Heart J,2021
2. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014
3. Lenient versus strict rate control in patients with atrial fibrillation;Van Gelder;N Engl J Med,2010
4. Calcium channel blockers improve exercise capacity and reduce N-terminal pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation;Ulimoen;Eur Heart J,2014
5. Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial;Kotecha;JAMA,2020
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction "Twindemic” - Shared Root Causes and Treatment Targets;Heart Rhythm;2024-09
2. β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases;Frontiers in Pharmacology;2024-06-25
3. Complexities of treating co‐morbidities in heart failure with preserved ejection fraction;ESC Heart Failure;2024-06-17
4. Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban;JAMA;2024-05-14
5. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation;European Heart Journal - Cardiovascular Pharmacotherapy;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3